Cardiac repair in Guinea pigs with human engineered heart tissue from induced pluripotent stem cells

Science Translational Medicine

Volumn 8, Issue 363, 2016, Pages

  Weinberger, Florian ^a,b   Breckwoldt, Kaja ^a,b   Pecha, Simon ^a,b   Kelly, Allen ^c,d   Geertz, Birgit ^a,b   Starbatty, Jutta ^a,b   Yorgan, Timur ^a   Cheng, Kai Hung ^e   Lessmann, Katrin ^a,b   Stolen, Tomas ^c,d   Marielle, Scherrer Crosbie ^e   Smith, Godfrey ^c,f   Reichenspurner, Hermann ^a,b   Hansen, Arne ^a,b   Eschenhagen, Thomas ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d Norwegian Council on Cardiovascular Disease   (Norway)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN A; TROPONIN T; UNCLASSIFIED DRUG;

ACTION POTENTIAL DURATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC MUSCLE CELL; CELL ATTACHED PATCH CLAMP; CELL DIFFERENTIATION; CELL FATE; CELL FREE SYSTEM; CELL PROLIFERATION; COLD INJURY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENGINEERED HEART TISSUE; FEMALE; GENE EXPRESSION; GUINEA PIG; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL NOISE RATIO; STEM CELL TRANSPLANTATION; ANIMAL; CARDIAC MUSCLE; CYTOLOGY; ECHOCARDIOGRAPHY; HEART; HEART SURGERY; HEART VENTRICLE; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; SCAR; SPLEEN; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; CARDIAC SURGICAL PROCEDURES; CELL DIFFERENTIATION; CELL PROLIFERATION; CICATRIX; ECHOCARDIOGRAPHY; FEMALE; GUINEA PIGS; HEART; HEART VENTRICLES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LUNG; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION; SPLEEN; TISSUE ENGINEERING;

EID: 84994509782     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf8781     Document Type: Article

References (34)

1. M. H. Soonpaa, L. J. Field, Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 83, 15-26 (1998).
2. M. A. Laflamme, C. E. Murry, Heart regeneration. Nature 473, 326-335 (2011).
3. O. Bergmann, R. D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabé-Heider, S. Walsh, J. Zupicich, K. Alkass, B. A. Buchholz, H. Druid, S. Jovinge, J. Frisén, Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
4. L. M. Ptaszek, M. Mansour, J. N. Ruskin, K. R. Chien, Towards regenerative therapy for cardiac disease. Lancet 379, 933-942 (2012).
5. S. J. Kattman, A. D. Witty, M. Gagliardi, N. C. Dubois, M. Niapour, A. Hotta, J. Ellis, G. Keller, Stagespecific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240 (2011).
6. T. Zhao, Z.-N. Zhang, Z. Rong, Y. Xu, Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 (2011).
7. M. Koyanagi-Aoi, M. Ohnuki, K. Takahashi, K. Okita, H. Noma, Y. Sawamura, I. Teramoto, M. Narita, Y. Sato, T. Ichisaka, N. Amano, A. Watanabe, A. Morizane, Y. Yamada, T. Sato, J. Takahashi, S. Yamanaka, Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 110, 20569-20574 (2013).
8. S. D. Schwartz, C. D. Regillo, B. L. Lam, D. Eliott, P. J. Rosenfeld, N. Z. Gregori, J.-P. Hubschman, J. L. Davis, G. Heilwell, M. Spirn, J. Maguire, R. Gay, J. Bateman, R. M. Ostrick, D. Morris, M. Vincent, E. Anglade, L. V. Del Priore, R. Lanza, Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 385, 509-516 (2014).
9. S. Reardon, D. Cyranoski, Japan stem-cell trial stirs envy. Nature 513, 287-288 (2014).
10. J. Muller-Ehmsen, Rebuilding a damaged heart: Long-Term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105, 1720-1726 (2002).
11. J. Dow, B. Z. Simkhovich, L. Kedes, R. A. Kloner, Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc. Res. 67, 301-307 (2005).
12. J. Riegler, M. Tiburcy, A. Ebert, E. Tzatzalos, U. Raaz, O. J. Abilez, Q. Shen, N. G. Kooreman, E. Neofytou, V. C. Chen, M. Wang, T. Meyer, P. S. Tsao, A. J. Connolly, L. A. Couture, J. D. Gold, W. H. Zimmermann, J. C. Wu, Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model. Circ. Res. 117, 720-730 (2015).
13. A. Moretti, M. Bellin, A. Welling, C. B. Jung, J. T. Lam, L. Bott-Flügel, T. Dorn, A. Goedel, C. Höhnke, F. Hofmann, M. Seyfarth, D. Sinnecker, A. Schömig, K.-L. Laugwitz, Patientspecific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409 (2010).
14. I. Mannhardt, K. Breckwoldt, D. Letuffe-Brenière, S. Schaaf, H. Schulz, C. Neuber, A. Benzin, T. Werner, A. Eder, T. Schulze, B. Klampe, T. Christ, M. N. Hirt, N. Huebner, A. Moretti, T. Eschenhagen, A. Hansen, Human engineered heart tissue: Analysis of contractile force. Stem Cell Rep. 7, 29-42 (2016).
15. S. Schaaf, A. Shibamiya, M. Mewe, A. Eder, A. Stöhr, M. N. Hirt, T. Rau, W.-H. Zimmermann, L. Conradi, T. Eschenhagen, A. Hansen, Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. Plos One 6, e26397 (2011).
16. J. Allard, K. Li, X. M. Lopez, S. Blanchard, P. Barbot, S. Rorive, C. Decaestecker, R. Pochet, D. Bohl, A. C. Lepore, I. Salmon, C. Nicaise, Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen. Med. 9, 437-452 (2014).
17. N. L. Walker, F. L. Burton, S. Kettlewell, G. L. Smith, S. M. Cobbe, Mapping of epicardial activation in a rabbit model of chronic myocardial infarction: Response to atrial, endocardial and epicardial pacing. J. Cardiovasc. Electrophysiol. 18, 862-868 (2007).
18. I. A. Ghouri, A. Kelly, F. L. Burton, G. L. Smith, O. J. Kemi, 2-Photon excitation fluorescence microscopy enables deeper high-resolution imaging of voltage and Ca2+ in intact mice, rat, and rabbit hearts. J. Biophotonics 8, 112-123 (2015).
19. W. Zimmermann, M. Didié, G. H. Wasmeier, U. Nixdorff, A. Hess, I. Melnychenko, O. Boy, W. L. Neuhuber, T. Eschenhagen, M. Didie, Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106, I151-I157 (2002).
20. M. Kawamura, S. Miyagawa, K. Miki, A. Saito, S. Fukushima, T. Higuchi, T. Kawamura, T. Kuratani, T. Daimon, T. Shimizu, T. Okano, Y. Sawa, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126, S29-S37 (2012).
21. H. Masumoto, T. Ikuno, M. Takeda, H. Fukushima, A. Marui, S. Katayama, T. Shimizu, T. Ikeda, T. Okano, R. Sakata, J. K. Yamashita, Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci. Rep. 4, 6716 (2014).
22. C. L. Mummery, J. Zhang, E. S. Ng, D. A. Elliott, A. G. Elefanty, T. J. Kamp, Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview. Circ. Res. 111, 344-358 (2012).
23. P. Kohl, P. Camelliti, Cardiac myocyte-nonmyocyte electrotonic coupling: Implications for ventricular arrhythmogenesis. Heart Rhythm 4, 233-235 (2007).
24. J. J. H. Chong, X. Yang, C. W. Don, E. Minami, Y.-W. Liu, J. J. Weyers, W. M. Mahoney, B. Van Biber, N. J. Palpant, J. A. Gantz, J. A. Fugate, V. Muskheli, G. M. Gough, K. W. Vogel, C. A. Astley, C. E. Hotchkiss, A. Baldessari, L. Pabon, H. Reinecke, E. A. Gill, V. Nelson, H.-P. Kiem, M. A. Laflamme, C. E. Murry, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277 (2014).
25. W.-H. Zimmermann, I. Melnychenko, G. Wasmeier, M. Didié, H. Naito, U. Nixdorff, A. Hess, L. Budinsky, K. Brune, B. Michaelis, S. Dhein, A. Schwoerer, H. Ehmke, T. Eschenhagen, Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12, 452-458 (2006).
26. Y. Shiba, S. Fernandes, W.-Z. Zhu, D. Filice, V. Muskheli, J. Kim, N. J. Palpant, J. Gantz, K. W. Moyes, H. Reinecke, B. Van Biber, T. Dardas, J. L. Mignone, A. Izawa, R. Hanna, M. Viswanathan, J. D. Gold, M. I. Kotlikoff, N. Sarvazyan, M. W. Kay, C. E. Murry, M. A. Laflamme, Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
27. O. Bergmann, S. Zdunek, A. Felker, M. Salehpour, K. Alkass, S. Bernard, S. L. Sjostrom, M. Szewczykowska, T. Jackowska, C. Dos Remedios, T. Malm, M. Andrä, R. Jashari, J. R. Nyengaard, G. Possnert, S. Jovinge, H. Druid, J. Frisén, Dynamics of cell generation and turnover in the human heart. Cell 161, 1566-1575 (2015).
28. G.-R. Li, J. Feng, L. Yue, M. Carrier, S. Nattel, Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ. Res. 78, 689-696 (1996).
29. R. Vaidyanathan, Y. S. Markandeya, T. J. Kamp, J. C. Makielski, C. T. January, L. L. Eckhardt, IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: An improved cardiomyocyte model to investigate inherited arrhythmia syndromes. Am. J. Physiol. Heart Circ. Physiol. 310, H1611-H1621 (2016).
30. M. A. Laflamme, S. Zbinden, S. E. Epstein, C. E. Murry, Cell-based therapy for myocardial ischemia and infarction: Pathophysiological mechanisms. Annu. Rev. Pathol. 2, 307-339 (2007).
31. H. Okano, M. Nakamura, K. Yoshida, Y. Okada, O. Tsuji, S. Nori, E. Ikeda, S. Yamanaka, K. Miura, Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 112, 523-533 (2013).
32. M. P. Maxwell, D. J. Hearse, D. M. Yellon, Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc. Res. 21, 737-746 (1987).
33. J. Takagawa, Y. Zhang, M. L. Wong, R. E. Sievers, N. K. Kapasi, Y. Wang, Y. Yeghiazarians, R. J. Lee, W. Grossman, M. L. Springer, Myocardial infarct size measurement in the mouse chronic infarction model: Comparison of area-And length-based approaches. J. Appl. Physiol. 102, 2104-2111 (2007).
34. A. Kelly, I. A. Ghouri, O. J. Kemi, M. J. Bishop, O. Bernus, F. H. Fenton, R. C. Myles, F. L. Burton, G. L. Smith, Subepicardial action potential characteristics are a function of depth and activation sequence in isolated rabbit hearts. Circ. Arrhythm. Electrophysiol. 6, 809-817 (2013).